Nortech Systems (NSYS) Cash from Financing Activities (2010 - 2026)
Nortech Systems (NSYS) reported Cash from Financing Activities of $2.3 million for Q1 2026, down 32.21% on a YoY basis from $3.4 million in Q1 2025, and up 145.94% sequentially from -$5.1 million in Q4 2025.
Nortech Systems (NSYS) Cash from Financing Activities (2010 - 2026) Analysis & Trends
Nortech Systems (NSYS) has 17 years of Cash from Financing Activities data on file, last reported at $2.3 million in Q1 2026.
- For the quarter ending Q1 2026, Cash from Financing Activities fell 32.21% year-over-year to $2.3 million; the trailing twelve-month figure through Mar 2026 stood at -$3.0 million (down 150.14% YoY), and the FY2025 full-year result was -$1.9 million, down 167.52% from the prior year.
- Cash from Financing Activities grew to $2.3 million in Q1 2026, from -$5.1 million in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $3.7 million in Q2 2022 to a low of -$5.1 million in Q4 2025.
- A 5-year average of -$42000.0 and a median of $274000.0 in 2024 frame the typical range for Cash from Financing Activities.
- Peak annual rise in Cash from Financing Activities reached 1157.66% in 2025, while the deepest fall reached 538.82% in 2025.
- Tracing NSYS's Cash from Financing Activities over 5 years: stood at -$3.2 million in 2022, then soared by 134.07% to $1.1 million in 2023, then slumped by 171.91% to -$796000.0 in 2024, then plunged by 538.82% to -$5.1 million in 2025, then surged by 145.94% to $2.3 million in 2026.
- Business Quant data shows NSYS's Cash from Financing Activities at $2.3 million in Q1 2026, -$5.1 million in Q4 2025, and $360000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -25.00 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -26.93 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Nortech Systems | 40.48 Mn | 38.52 Mn | 4.70 Mn | 2.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.34 Mn |
| Mar 31, 2026 | 2.34 Mn |
| Dec 31, 2025 | -5.09 Mn |
| Dec 31, 2025 | -5.09 Mn |
| Sep 30, 2025 | 360,000.00 |
| Sep 30, 2025 | 360,000.00 |
| Jun 30, 2025 | -588,000.00 |
| Jun 30, 2025 | -588,000.00 |
| Mar 31, 2025 | 3.45 Mn |
| Mar 31, 2025 | 3.45 Mn |
| Dec 31, 2024 | -796,000.00 |
| Dec 31, 2024 | -796,000.00 |
| Sep 30, 2024 | 1.22 Mn |
| Sep 30, 2024 | 1.22 Mn |
| Jun 30, 2024 | 2.07 Mn |
| Jun 30, 2024 | 2.07 Mn |
| Mar 31, 2024 | 274,000.00 |
| Mar 31, 2024 | 274,000.00 |
| Dec 31, 2023 | 1.11 Mn |
| Dec 31, 2023 | 1.11 Mn |